SVB Leerink's Geoff Porges on Pfizer Covid treatment: Really terrific news, but don't expect it to flood the market

Geoff Porges, SVB Leerink, joins 'Closing Bell' to discuss Pfizer's antiviral Covid-19 pill and how it will impact companies like Merck.